Infectious diseases
Every year, millions of people die from infectious diseases.
Our decades of research in infectious diseases have led to profound scientific advances
We’ve been combating global health threats caused by infectious diseases for more than a century. From developing one of the first antibiotics, to pioneering research in HIV, to contributing to the fight against COVID-19, our focus has always been on the prevention and treatment of diseases that threaten people and communities around the world.
The world is counting on us to bring forward new approaches to existing diseases and our work is far from done.
Our work in infectious diseases
years committed to research to help combat the challenges of the HIV epidemic
the year we began producing penicillin G
investigator-initiated antimicrobial stewardship programs funded across the globe
COVID-19
Dedicated to the fight against COVID-19
We are inspired by a shared vision and mission to save and improve lives and have been committed to developing an effective response to the COVID-19 pandemic from the beginning. This includes both our investment in research that could help protect Canadians from this pandemic, as well as supporting the communities in which we work and live in.
HIV
Our legacy in innovative HIV science continues
We remember when HIV was one of society's most daunting challenges, when millions of people lost their lives to the devastating AIDS epidemic. Our scientists embarked on an urgent mission to unravel and understand the virus, which led to groundbreaking research in HIV.
We are still driven to do more. We are pushing the boundaries of HIV science because unmet medical need still endures. Eradication of the virus is our ultimate goal.
Antibiotics
Continuing research and striving for improvements in the use of antibiotics
We continue our efforts, because we know the world needs it.
Ebola
Joining a partnership to combat a deadly virus
Since the emergence of the Ebola virus in 1976, periodic outbreaks have been a global health challenge. We are proud to be part of the global public-private partnership that has united government, industry, community groups, scientists, health care workers and ordinary people, to come together to help fight this deadly disease.
